Real-World Evidence of Tofacinitib in Ulcerative Colitis: Short-Term and Long-Term Effectiveness and Safety
2022 · The American Journal of Gastroenterology · 31 citations
https://doi.org/10.14309/ajg.0000000000002145
J
Jordina Llaó
Althaia(ES)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
784
Citations
14
h-index
19
i10-index
Jordina Llaó is an academic researcher from Althaia. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Colorectal Cancer Screening and Detection. The author has an h-index of 14, co-authored 41 publications.
Papers by this author
worksRisk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case–Control Study (COVID-19-EII)
2022 · Journal of Clinical Medicine · 4 citations
https://doi.org/10.3390/jcm11247540
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
2024 · Therapeutic Advances in Gastroenterology · 1 citations
https://doi.org/10.1177/17562848231221713
Comparative Study on the Management and Outcomes of Postoperative Crohn's Disease in Older Patients: Data From the ENEIDA Registry
2025 · United European Gastroenterology Journal · 1 citations
https://doi.org/10.1002/ueg2.70150
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat